Prevention by (±)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol

British Journal of Pharmacology

Volumn 118, Issue 2, 1996, Pages 421-427

  Andersen, Heidi L ^a   Kilpatrick, Ian C ^a  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

5 HT(1A) receptor; 8 OH DPAT; Catalepsy; Caudate putamen; DOPAC; Dopamine; Haloperidol; HVA; Medial prefrontal cortex; Metabolism; Nucleus accumbens

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HALOPERIDOL; HOMOVANILLIC ACID; DOPAMINE RECEPTOR BLOCKING AGENT; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; METABOLISM;

3,4-DIHYDROXYPHENYLACETIC ACID; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; CATALEPSY; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; HOMOVANILLIC ACID; MALE; RATS; SEROTONIN AGONISTS;

EID: 0029665952     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15419.x     Document Type: Article

References (62)

1. AHLENIUS, S., HILLEGAART, V. & WIJKSTRÖM, A. (1989). Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat. Naunyn-Schmied. Arch. Pharmacol., 339, 551-556.
2. AHLENIUS, S., HILLEGAART, V. & WIJKSTRÖM, A. (1990). Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. J. Pharm. Pharmacol., 42, 285-288.
3. ANDERSEN, H.L. & KILPATRICK, I.C. (1995). Catalepsy, brain dopamine metabolism and the interaction between haloperidol and 8-OH-DPAT. Br. J. Pharmacol., 114, 121P.
4. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmied. Arch. Pharmacol., 347, 353-362.
5. ARBORELIUS, L., NOMIKOS, G.G., HACKSELL, U. & SVENSSON, T.H. (1993b). (R)-S-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex. Acta Physiol. Scand., 148, 465-466.
6. ARNT, J. & HYTTEL, J. (1990). Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques. J. Neural Transm., 80, 33-50.
7. AZMITIA, E.C. & SEGAL, M. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179, 641-668.
8. BALDESSARINI, R.J. & TARSY, D. (1980). Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu. Rev. Neurosci., 3, 23-41.
9. BALSARA, J.J., JADHAV, J.H. & CHANDORKAR, A.C. (1979). Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology, 62, 67-69.
10. BENLOUCIF, S. & GALLOWAY, M.P. (1991). Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol., 200, 1-8.
11. BENLOUCIF, S., KEEGAN, M.J. & GALLOWAY, M.P. (1993). Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther., 265, 373-377.
12. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Neuropharmacology, 34, 269-279.
13. 1 receptor agonists and antagonists. J. Neurochem., 48, 824-831.
14. 2-dopamine receptor-mediated catalepsy. Brain Res., 450, 403-407.
15. CARTER, C.J. & PYCOCK, C.J. (1977). Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats. Br. J. Pharmacol., 60, 267P.
16. CASEY, D.E. (1991). Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. Schizophrenia Res., 4, 109-120.
17. 1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res., 561, 51-60.
18. CHIODO, L.A., BANNON, M.J., GRACE, A.A., ROTH, R.H. & BUNNEY, B.S. (1984). Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience, 12, 1-16.
19. COMMISSIONG, J.W. (1985). Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity. Biochem. Pharmacol., 34, 1127-1131.
20. 1A receptors that are negatively coupled to adenylate cyclase. Mol. Pharmacol., 39, 780-787.
21. ESSIG, E.C. & KILPATRICK, I.C. (1991a). Haloperidol-induced increases in rat amygdaloid dopamine metabolism: evidence for independence from postsynaptic feedback mechanisms. Neurosci. Lett., 123, 261-264.
22. ESSIG, E.C. & KILPATRICK, I.C. (1991b). Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala. Psychopharmacology, 104, 194-200.
23. FREGNAN, G.B. & VIDALI, M. (1982). Appearance of extrapyramidal symptoms: interaction between neuroleptics and other CNS-active drugs. Pharmacology, 25, 102-110.
24. FUENMAYOR, L.D. & VOGT, M. (1979). Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative. Br. J. Pharmacol., 67, 115-122.
25. GARCIA-MUNOZ, M., NICOLAOU, N.M., TULLOCH, I.F., WRIGHT, A.K. & ARBUTHNOTT, G.W. (1977). Feedback loop or output pathway in striato-nigral fibres? Nature, 265, 363-365.
26. GOLEMBIOWSKA, K. & WEDZONY, K. (1993). Enhancement by ipsapirone of dopamine release in the rat striatum. Pol. J. Pharmacol., 45, 299-308.
27. HAND, T.H., HU, X.-T. & WANG, R.Y. (1987). Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res., 415, 257-269.
28. HARTGRAVES, S.L. & KELLY, P.H. (1984). Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy. Brain Res., 307, 47-54.
29. HICKS, P.B. (1990). The effect of serotonergie agents on haloperidol-induced catalepsy. Life Sci., 47, 1609-1615.
30. 1A receptors prevents haloperidol-induced catalepsy without influencing the concurrently enhanced dopamine utilisation in the rat brain. Br. J. Pharmacol., 111, 11P.
31. HJORTH, S., CARLSSON, A., LINDBERG, P., SANCHEZ, D., WIKSTRÖM, H., ARVIDSSON, L.E., HACKSELL, U. & NILSSON, J.L.G. (1982),8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulation activity. J. Neural. Transm., 55, 169-188.
32. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology, 27, 515-518.
33. 3 receptor agonist 2-methytserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res., 513, 156-160.
34. 1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum. J. Pharmacol. Exp. Ther., 266, 133-141.
35. KILPATRICK, I.C. (1991). Rapid, semi-automated HPLC analyses of catecholamines, indoleamines and metabolites in microdissected brain regions and brain slice superfusates using coulometric detection. In Neuroendocrine Research Methods. ed. Greenstein, B.D. pp. 527-553. London: Harwood Academic.
36. KILPATRICK, I.C., JONES, M.W. & PHILLIPSON, O.T. (1986). A semi-automated analysis method for catecholamines, indoleamines and some prominent metabolites in microdissected regions of the nervous system. An isocratic high performance liquid chromatographic technique employing coulometric detection and minimal sample preparation. J. Neurochem., 46, 1865-1876.
37. KILPATRICK, I.C. & ROGERS, H.J. (1987). Activation of dopamine-D2 receptors inhibits the release of endogenous dopamine from slices of the rat prefrontal cortex. Br. J. Pharmacol., 92, 706P.
38. KLEMM, W.R. (1989). Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol., 32, 403-422.
39. KLOCKGETHER, T., SCHWARZ, M., TURSKI, L. & SONTAG, K.-H. (1988). Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex. Exp. Brain Res., 70, 445-447.
40. KOSTOWSKI, W., GUMULKA, W. & CZLONKOWSKI, A. (1972). Reduced cataleptogenic effect of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine. Brain Res., 48, 443-446.
41. 1 sites in the rat brain. Brain Res., 291, 159-163.
42. NEAL-BELIVEAU, B.S., JOYCE, J.N. & LUCKI, I. (1993). Serotonergic involvement in haloperidol-induced catalepsy. J. Pharmacol. Exp. Ther., 265, 207-217.
43. 7 agonist, 8-OH-DPAT, is mediated by postsynaptic receptors. Br. J. Pharmacol., 112, 491P.
44. ÖGREN, S.O., HALL, H., KÖHLER, C., MAGNUSSON, O., LINDBOM, L.-O., ÄNGEBY, K. & FLORVALL, L. (1984). Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur. J. Pharmacol., 102, 459-474.
45. 2 dopamine receptors in neuroleptic-induced catalepsy. Eur. J. Pharmacol., 182, 327-334.
46. PARSONS, L.H. & JUSTICE, J.B. JR. (1993). Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res., 606, 195-199.
47. PERRY, K.W. & FULLER, R.W. (1989). Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. Biochem. Pharmacol., 38, 3169-3173.
48. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res., 606, 273-285.
49. SANBERG, P.R. (1980). Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature, 284, 472-473.
50. SARNEK, J. & BARAN, L. (1975). The effect of 5-hydroxytryptamine synthesis inhibitors on neuroleptic-induced catalepsy in rats. Arch. Immunol. Ther. Exp., 23, 511-516.
51. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol., 96, 283-290.
52. SMITH, C.F.C. & CUTTS, S. (1990). Dopamine agonist activity of 8-OH-DPAT. Arch. Int. Pharmacodyn. Ther., 306, 106-113.
53. TALMACIU, R.K., HOFFMANN, I.S. & CUBEDDU, L.X. (1986). Dopamine autoreceptors modulate dopamine release from the prefrontal cortex. J. Neurochem., 47, 865-870.
54. 1A receptor and of catecholaminergic systems in the behavioural responses to 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) in the rat. Eur. J. Pharmacol., 106, 271-282.
55. WADENBERG, M.L. & AHLENIUS, S. (1991). Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effect without catalepsy. J. Neural Transm., 83, 43-53.
56. 1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Pharmacol. Biochem. Behav., 47, 509-513.
57. WADENBERG, M.L., HILLEGAART, V. & BERGE, O.G. (1993). Supraspinal mediation of dopamine-serotonin interactions in extrapyramidal motor functions in the rat. NeuroReport, 4, 59-61.
58. WESTERINK, B.H.C. & DE VRIES, J.B. (1989). On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci. Lett., 99, 197-207.
59. WOLF, M.E. & ROTH, R.H. (1987). Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors. Neuropharmacology, 26, 1053-1059.
60. WUERTHELE, S.M. & MOORE, K.E. (1979). Effects of dopaminergic antagonists on striatal DOPAC concentrations and α-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid. J. Pharm. Pharmacol., 31, 180-182.
61. WUERTHELE, S.M. & MOORE, K.E. (1980). Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres. J. Pharm. Pharmacol., 32, 507-510.
62. ZETTERSTRÖM, T., SHARP, T. & UNGERSTEDT, U. (1984). Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur. J. Pharmacol., 106, 27-37.